Open Access

Discussion and close: anticoagulation in atrial fibrillation and beyond.

Topic: Pathophysiology and Mechanisms
Sponsored by Boehringer Ingelheim

Congress Presentation

About the speakers

Doctor Jonathan Halperin

Mount Sinai Medical Center, New York (United States of America)
12 presentations
0 follower

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
92 presentations
9 followers

4 more presentations in this session

The heart of the matter: selecting the right OAC for stroke prevention in patients with AF.

Speaker: Doctor J. Halperin (New York, US)

Thumbnail

Latest developments for uninterrupted anticoagulation in atrial fibrillation ablation.

Speaker: Professor S. Willems (Hamburg, DE)

Thumbnail

Latest developments for dual vs triple antithrombotic therapy post-PCI.

Speaker: Professor G. Lip (Liverpool, GB)

Thumbnail

Does OAC reversal matter to your cardiac patients?

Speaker: Professor C. Pollack (Jackson, US)

Thumbnail

Access the full session

Dabigatran use in diverse cardiology settings

Speakers: Doctor J. Halperin, Professor G. Lip, Doctor J. Halperin, Professor S. Willems, Professor G. Lip...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb